| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | deaminase binding | 1.19e-07 | 4 | 63 | 3 | GO:1990827 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 1.08e-06 | 25 | 63 | 4 | GO:0070034 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 2.48e-06 | 9 | 63 | 3 | GO:0017151 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 3.89e-06 | 34 | 63 | 4 | GO:0008266 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 6.81e-06 | 39 | 63 | 4 | GO:0008187 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 1.33e-05 | 15 | 63 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 5.78e-05 | 24 | 63 | 3 | GO:0140517 | |
| GeneOntologyMolecularFunction | bisphosphoglycerate mutase activity | 5.85e-05 | 4 | 63 | 2 | GO:0004082 | |
| GeneOntologyMolecularFunction | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity | 5.85e-05 | 4 | 63 | 2 | GO:0046538 | |
| GeneOntologyMolecularFunction | phosphoglycerate mutase activity | 5.85e-05 | 4 | 63 | 2 | GO:0004619 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXJ2 HOXA5 SOX3 HIVEP3 SOX15 MLXIPL MEF2B ZBTB7C E2F7 ZNF362 EP300 SMAD1 SMAD5 | 1.13e-04 | 1244 | 63 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXJ2 HOXA5 SOX3 HIVEP3 SOX15 MLXIPL MEF2B ZBTB7C E2F7 ZNF362 EP300 SMAD1 SMAD5 | 1.40e-04 | 1271 | 63 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXJ2 HOXA5 SOX3 HIVEP3 SOX15 MLXIPL MEF2B ZBTB7C E2F7 ZNF362 TAF1 EP300 SMAD1 SMAD5 | 1.45e-04 | 1459 | 63 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | SMAD binding | 1.57e-04 | 86 | 63 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.09e-04 | 187 | 63 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 3.27e-04 | 104 | 63 | 4 | GO:0016407 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 3.63e-04 | 560 | 63 | 8 | GO:0001228 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.82e-04 | 303 | 63 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 3.90e-04 | 566 | 63 | 8 | GO:0001216 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXJ2 HOXA5 SOX3 HIVEP3 SOX15 MLXIPL MEF2B ZBTB7C YLPM1 E2F7 SHOX SMAD1 SMAD5 | 3.92e-04 | 1412 | 63 | 13 | GO:0000981 |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 4.19e-04 | 111 | 63 | 4 | GO:0003727 | |
| GeneOntologyMolecularFunction | primary miRNA binding | 4.34e-04 | 10 | 63 | 2 | GO:0070878 | |
| GeneOntologyMolecularFunction | intramolecular phosphotransferase activity | 5.29e-04 | 11 | 63 | 2 | GO:0016868 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 1.29e-03 | 17 | 63 | 2 | GO:0070411 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.91e-03 | 562 | 63 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.92e-03 | 78 | 63 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.99e-03 | 417 | 63 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.32e-03 | 582 | 63 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.44e-03 | 753 | 63 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 HNRNPCL1 SMARCE1 BCL3 DCC ARID1A MIDEAS HNRNPC EP300 HNRNPCL2 | 3.23e-03 | 1160 | 63 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | nucleosome binding | 3.68e-03 | 98 | 63 | 3 | GO:0031491 | |
| GeneOntologyMolecularFunction | intramolecular transferase activity | 3.77e-03 | 29 | 63 | 2 | GO:0016866 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 4.12e-03 | 102 | 63 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 4.29e-03 | 31 | 63 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 6.04e-03 | 875 | 63 | 8 | GO:0019904 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 6.77e-03 | 238 | 63 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | chromatin binding | 8.47e-03 | 739 | 63 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 HNRNPCL1 SMARCE1 BCL3 DCC ARID1A MIDEAS HNRNPC EP300 HNRNPCL2 | 9.53e-03 | 1356 | 63 | 10 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 9.86e-03 | 140 | 63 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | lipopolysaccharide binding | 1.01e-02 | 48 | 63 | 2 | GO:0001530 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.13e-02 | 51 | 63 | 2 | GO:0004402 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 FOXJ2 HOXA5 SOX3 SOX15 MLXIPL WASL MEF2B PPP2R5D ZBTB7C ATXN1 E2F7 SHOX TAF1 BCL3 EP300 SMAD1 SMAD5 | 1.03e-07 | 1390 | 63 | 18 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 5.40e-07 | 6 | 63 | 3 | GO:0090367 | |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 9.42e-07 | 7 | 63 | 3 | GO:0090365 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TRERF1 SOX3 SOX15 MLXIPL PER3 ATXN1 YLPM1 E2F7 SMARCE1 TAF1 BCL3 ARID1A MIDEAS ZNF282 EP300 SMAD5 | 3.21e-06 | 1399 | 63 | 16 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TRERF1 SOX3 SOX15 MLXIPL PER3 ATXN1 YLPM1 E2F7 SMARCE1 TAF1 BCL3 ARID1A MIDEAS ZNF282 EP300 SMAD5 | 3.65e-06 | 1413 | 63 | 16 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.64e-05 | 266 | 63 | 7 | GO:0033044 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 2.36e-05 | 112 | 63 | 5 | GO:0032204 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 3.39e-05 | 60 | 63 | 4 | GO:0032210 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 5.89e-05 | 69 | 63 | 4 | GO:1904356 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomerase | 5.95e-05 | 25 | 63 | 3 | GO:0032211 | |
| GeneOntologyBiologicalProcess | mRNA modification | 6.72e-05 | 26 | 63 | 3 | GO:0016556 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 9.05e-05 | 77 | 63 | 4 | GO:0007004 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.15e-04 | 31 | 63 | 3 | GO:0070935 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.21e-04 | 83 | 63 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | osteoblast fate commitment | 1.37e-04 | 6 | 63 | 2 | GO:0002051 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomere lengthening | 1.39e-04 | 33 | 63 | 3 | GO:1904357 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.52e-04 | 88 | 63 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 1.62e-04 | 168 | 63 | 5 | GO:0000723 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 1.66e-04 | 90 | 63 | 4 | GO:0010833 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | PPP1R8 MLXIPL HNRNPCL1 NAF1 PGAM4 PGAM1 HNRNPC EP300 HNRNPCL2 | 2.50e-04 | 696 | 63 | 9 | GO:0034655 |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 2.58e-04 | 101 | 63 | 4 | GO:1902369 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 2.78e-04 | 418 | 63 | 7 | GO:0009895 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 2.86e-04 | 42 | 63 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 2.86e-04 | 42 | 63 | 3 | GO:0032205 | |
| GeneOntologyBiologicalProcess | signal transduction by p53 class mediator | 2.94e-04 | 191 | 63 | 5 | GO:0072331 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 3.07e-04 | 564 | 63 | 8 | GO:0051052 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA biosynthetic process | 3.07e-04 | 43 | 63 | 3 | GO:2000279 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX3 SOX15 MLXIPL PER3 ATXN1 YLPM1 E2F7 TAF1 ARID1A EP300 SMAD5 | 3.12e-04 | 1053 | 63 | 11 | GO:0000122 |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 3.29e-04 | 44 | 63 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | telomere organization | 3.55e-04 | 199 | 63 | 5 | GO:0032200 | |
| GeneOntologyBiologicalProcess | glycolytic process | 3.58e-04 | 110 | 63 | 4 | GO:0006096 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 4.10e-04 | 114 | 63 | 4 | GO:0046032 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 4.53e-04 | 117 | 63 | 4 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 4.53e-04 | 117 | 63 | 4 | GO:0009181 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 4.53e-04 | 49 | 63 | 3 | GO:0042771 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 4.82e-04 | 119 | 63 | 4 | GO:0019364 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 4.98e-04 | 120 | 63 | 4 | GO:0046031 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 5.14e-04 | 121 | 63 | 4 | GO:0009191 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 5.47e-04 | 123 | 63 | 4 | GO:0072526 | |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 5.64e-04 | 124 | 63 | 4 | GO:0001704 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 5.64e-04 | 124 | 63 | 4 | GO:0009134 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 6.78e-04 | 349 | 63 | 6 | GO:0014706 | |
| GeneOntologyBiologicalProcess | glyceraldehyde-3-phosphate biosynthetic process | 7.01e-04 | 13 | 63 | 2 | GO:0046166 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 7.13e-04 | 132 | 63 | 4 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 7.13e-04 | 132 | 63 | 4 | GO:0009179 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 7.97e-04 | 136 | 63 | 4 | GO:0045445 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 8.42e-04 | 138 | 63 | 4 | GO:2000278 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 9.36e-04 | 142 | 63 | 4 | GO:0006090 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 9.61e-04 | 143 | 63 | 4 | GO:0009185 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.08e-03 | 382 | 63 | 6 | GO:0030217 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 1.12e-03 | 149 | 63 | 4 | GO:0009132 | |
| GeneOntologyBiologicalProcess | ATP metabolic process | 1.13e-03 | 257 | 63 | 5 | GO:0046034 | |
| GeneOntologyBiologicalProcess | muscle structure development | 1.13e-03 | 858 | 63 | 9 | GO:0061061 | |
| GeneOntologyBiologicalProcess | circulatory system development | FOXJ2 HOXA5 FZD7 JCAD COL8A1 MEF2B CNTRL E2F7 ARID1A EP300 SMAD1 SMAD5 | 1.24e-03 | 1442 | 63 | 12 | GO:0072359 |
| GeneOntologyBiologicalProcess | trophoblast giant cell differentiation | 1.52e-03 | 19 | 63 | 2 | GO:0060707 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 1.52e-03 | 558 | 63 | 7 | GO:0060537 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | FOXJ2 HOXA5 FZD7 JCAD COL8A1 NF2 E2F7 BCL3 ARID1A EP300 SMAD1 SMAD5 | 1.57e-03 | 1483 | 63 | 12 | GO:0048646 |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 5.18e-07 | 6 | 63 | 3 | GO:1990826 | |
| GeneOntologyCellularComponent | pronucleus | 1.45e-06 | 28 | 63 | 4 | GO:0045120 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 PPP1R8 MLXIPL HNRNPCL1 SETD1B DROSHA E2F7 SMARCE1 TAF1 ARID1A MIDEAS HNRNPC HNRNPCL2 SMAD1 SMAD5 | 1.07e-05 | 1377 | 63 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | transcription regulator complex | TRERF1 SOX15 MLXIPL MEF2B E2F7 TAF1 MIDEAS EP300 SMAD1 SMAD5 | 1.08e-05 | 596 | 63 | 10 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | FOXJ2 HOXA5 SOX3 SOX15 MLXIPL MEF2B E2F7 SHOX SMARCE1 TAF1 ARID1A HNRNPC EP300 SMAD1 SMAD5 | 2.51e-05 | 1480 | 63 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 5.72e-05 | 25 | 63 | 3 | GO:0005697 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 2.47e-04 | 8 | 63 | 2 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 3.96e-04 | 10 | 63 | 2 | GO:0071141 | |
| GeneOntologyCellularComponent | bBAF complex | 3.96e-04 | 10 | 63 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 7.95e-04 | 14 | 63 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 7.95e-04 | 14 | 63 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 1.04e-03 | 16 | 63 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.37e-03 | 272 | 63 | 5 | GO:0090575 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 3.14e-03 | 97 | 63 | 3 | GO:0071013 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 3.68e-03 | 30 | 63 | 2 | GO:0016514 | |
| HumanPheno | Hypoplastic fifth toenail | 4.11e-05 | 19 | 19 | 3 | HP:0011937 | |
| HumanPheno | Obesity | 7.29e-05 | 425 | 19 | 8 | HP:0001513 | |
| HumanPheno | Sleep abnormality | 1.21e-04 | 596 | 19 | 9 | HP:0002360 | |
| HumanPheno | Decreased circulating ACTH concentration | 1.68e-04 | 30 | 19 | 3 | HP:0002920 | |
| HumanPheno | Abnormal prolactin level | 1.68e-04 | 30 | 19 | 3 | HP:0040086 | |
| HumanPheno | Thick eyebrow | 1.95e-04 | 154 | 19 | 5 | HP:0000574 | |
| HumanPheno | Increased body weight | 2.04e-04 | 491 | 19 | 8 | HP:0004324 | |
| HumanPheno | Abnormal toenail morphology | 2.86e-04 | 167 | 19 | 5 | HP:0008388 | |
| HumanPheno | Intellectual disability, moderate | 3.28e-04 | 172 | 19 | 5 | HP:0002342 | |
| HumanPheno | Pituitary hypothyroidism | 3.42e-04 | 38 | 19 | 3 | HP:0008245 | |
| HumanPheno | Hypogonadotropic hypogonadism | 3.94e-04 | 179 | 19 | 5 | HP:0000044 | |
| HumanPheno | Small nail | 4.37e-04 | 183 | 19 | 5 | HP:0001792 | |
| HumanPheno | Meningioma | 5.29e-04 | 44 | 19 | 3 | HP:0002858 | |
| HumanPheno | Abnormal circulating adrenocorticotropin concentration | 5.29e-04 | 44 | 19 | 3 | HP:0011043 | |
| HumanPheno | Abnormal thalamus morphology | 6.85e-04 | 48 | 19 | 3 | HP:0010663 | |
| HumanPheno | Amenorrhea | 6.88e-04 | 202 | 19 | 5 | HP:0000141 | |
| HumanPheno | Neoplasm of the posterior pituitary | 7.11e-04 | 11 | 19 | 2 | HP:0011752 | |
| HumanPheno | Focal T2 hypointense thalamic lesion | 7.11e-04 | 11 | 19 | 2 | HP:0012691 | |
| HumanPheno | Spinal meningioma | 7.11e-04 | 11 | 19 | 2 | HP:0100010 | |
| HumanPheno | Intracranial meningioma | 7.11e-04 | 11 | 19 | 2 | HP:0100009 | |
| HumanPheno | Abnormal kinetic perimetry test | 7.11e-04 | 11 | 19 | 2 | HP:0030591 | |
| HumanPheno | Spinocerebellar tract degeneration | 7.11e-04 | 11 | 19 | 2 | HP:0002503 | |
| HumanPheno | Aplastic/hypoplastic toenail | 7.85e-04 | 117 | 19 | 4 | HP:0010624 | |
| HumanPheno | Impairment in personality functioning | MLXIPL PPP2R5D SETD1B PER3 NF2 ANXA11 RNF216 SMARCE1 TAF1 ARID1A EP300 | 8.48e-04 | 1141 | 19 | 11 | HP:0031466 |
| HumanPheno | Weak extraocular muscles | 8.51e-04 | 12 | 19 | 2 | HP:0007715 | |
| HumanPheno | Hypothalamic hypothyroidism | 8.51e-04 | 12 | 19 | 2 | HP:0008237 | |
| HumanPheno | Hemifacial spasm | 8.51e-04 | 12 | 19 | 2 | HP:0010828 | |
| HumanPheno | Abnormal hypothalamus physiology | 9.16e-04 | 53 | 19 | 3 | HP:0012285 | |
| HumanPheno | Hypoplastic fingernail | 9.16e-04 | 53 | 19 | 3 | HP:0001804 | |
| HumanPheno | Decreased pulmonary function | 1.00e-03 | 13 | 19 | 2 | HP:0005952 | |
| HumanPheno | Progressive pulmonary function impairment | 1.00e-03 | 13 | 19 | 2 | HP:0006520 | |
| HumanPheno | Abnormal fifth cranial nerve physiology | 1.00e-03 | 13 | 19 | 2 | HP:0031911 | |
| HumanPheno | Chromosomal breakage induced by ionizing radiation | 1.00e-03 | 13 | 19 | 2 | HP:0010997 | |
| HumanPheno | Abnormality of the spinocerebellar tracts | 1.00e-03 | 13 | 19 | 2 | HP:0003133 | |
| HumanPheno | Neuralgia | 1.00e-03 | 13 | 19 | 2 | HP:0033345 | |
| HumanPheno | Trigeminal neuralgia | 1.00e-03 | 13 | 19 | 2 | HP:0100661 | |
| HumanPheno | Abnormal fifth cranial nerve morphology | 1.00e-03 | 13 | 19 | 2 | HP:0010824 | |
| HumanPheno | Gaze-evoked nystagmus | 1.02e-03 | 55 | 19 | 3 | HP:0000640 | |
| HumanPheno | Abnormal posterior pituitary morphogenesis | 1.02e-03 | 55 | 19 | 3 | HP:0011751 | |
| HumanPheno | Abnormality of the sense of smell | 1.07e-03 | 127 | 19 | 4 | HP:0004408 | |
| HumanPheno | Thin upper lip vermilion | 1.07e-03 | 339 | 19 | 6 | HP:0000219 | |
| HumanPheno | Thin lips | 1.07e-03 | 339 | 19 | 6 | HP:0000213 | |
| HumanPheno | Long eyelashes | 1.13e-03 | 129 | 19 | 4 | HP:0000527 | |
| HumanPheno | Prenatal growth deficiency | 1.14e-03 | 631 | 19 | 8 | HP:0001515 | |
| HumanPheno | Intrauterine growth retardation | 1.14e-03 | 631 | 19 | 8 | HP:0001511 | |
| HumanPheno | Abnormal central sensory function | 1.17e-03 | 14 | 19 | 2 | HP:0011730 | |
| HumanPheno | Brain stem compression | 1.17e-03 | 14 | 19 | 2 | HP:0002512 | |
| HumanPheno | Increased sensitivity to ionizing radiation | 1.17e-03 | 14 | 19 | 2 | HP:0011133 | |
| HumanPheno | Hypoplastic fifth fingernail | 1.17e-03 | 14 | 19 | 2 | HP:0008398 | |
| HumanPheno | Enlarged pituitary gland | 1.17e-03 | 14 | 19 | 2 | HP:0012505 | |
| HumanPheno | Cerebellar malformation | 1.27e-03 | 487 | 19 | 7 | HP:0002438 | |
| HumanPheno | Secondary growth hormone deficiency | 1.34e-03 | 15 | 19 | 2 | HP:0008240 | |
| HumanPheno | Ear pain | 1.34e-03 | 15 | 19 | 2 | HP:0030766 | |
| HumanPheno | Thick lower lip vermilion | 1.38e-03 | 136 | 19 | 4 | HP:0000179 | |
| HumanPheno | Unsteady gait | 1.41e-03 | 357 | 19 | 6 | HP:0002317 | |
| HumanPheno | Hemiplegia/hemiparesis | 1.50e-03 | 240 | 19 | 5 | HP:0004374 | |
| HumanPheno | Heteronymous hemianopia | 1.53e-03 | 16 | 19 | 2 | HP:0030517 | |
| HumanPheno | Bitemporal hemianopia | 1.53e-03 | 16 | 19 | 2 | HP:0030521 | |
| HumanPheno | Square face | 1.53e-03 | 16 | 19 | 2 | HP:0000321 | |
| MousePheno | abnormal gastrulation | PPP1R8 WASL HNRNPCL1 NF2 YLPM1 ARID1A DENND1A HNRNPC EP300 HNRNPCL2 SMAD1 SMAD5 | 6.73e-08 | 469 | 50 | 12 | MP:0001695 |
| MousePheno | abnormal developmental patterning | PPP1R8 WASL HNRNPCL1 NF2 YLPM1 ARID1A DENND1A HNRNPC EP300 HNRNPCL2 SMAD1 SMAD5 | 6.29e-07 | 577 | 50 | 12 | MP:0002084 |
| MousePheno | failure to gastrulate | 3.92e-06 | 119 | 50 | 6 | MP:0001696 | |
| MousePheno | absent heartbeat | 9.37e-05 | 25 | 50 | 3 | MP:0004086 | |
| MousePheno | abnormal extraembryonic ectoderm morphology | 1.80e-04 | 31 | 50 | 3 | MP:0010736 | |
| Domain | hnRNP_C | 6.92e-07 | 6 | 62 | 3 | IPR017347 | |
| Domain | HMG_BOX_2 | 3.07e-05 | 54 | 62 | 4 | PS50118 | |
| Domain | HMG_box_dom | 6.40e-05 | 65 | 62 | 4 | IPR009071 | |
| Domain | Phosphogly_mut1 | 6.48e-05 | 4 | 62 | 2 | IPR005952 | |
| Domain | Dwarfin | 3.00e-04 | 8 | 62 | 2 | IPR013790 | |
| Domain | DWB | 3.00e-04 | 8 | 62 | 2 | SM00524 | |
| Domain | MH2 | 3.00e-04 | 8 | 62 | 2 | PS51076 | |
| Domain | MH1 | 3.00e-04 | 8 | 62 | 2 | PS51075 | |
| Domain | - | 3.00e-04 | 8 | 62 | 2 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 3.00e-04 | 8 | 62 | 2 | IPR013019 | |
| Domain | MH2 | 3.00e-04 | 8 | 62 | 2 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 3.00e-04 | 8 | 62 | 2 | IPR001132 | |
| Domain | PG/BPGM_mutase_AS | 3.85e-04 | 9 | 62 | 2 | IPR001345 | |
| Domain | PGAM | 4.80e-04 | 10 | 62 | 2 | SM00855 | |
| Domain | PG_MUTASE | 4.80e-04 | 10 | 62 | 2 | PS00175 | |
| Domain | SMAD_FHA_domain | 6.86e-04 | 52 | 62 | 3 | IPR008984 | |
| Domain | MAD_homology1_Dwarfin-type | 7.00e-04 | 12 | 62 | 2 | IPR003619 | |
| Domain | DWA | 7.00e-04 | 12 | 62 | 2 | SM00523 | |
| Domain | His_Phos_1 | 7.00e-04 | 12 | 62 | 2 | PF00300 | |
| Domain | His_Pase_superF_clade-1 | 7.00e-04 | 12 | 62 | 2 | IPR013078 | |
| Domain | MH1 | 7.00e-04 | 12 | 62 | 2 | PF03165 | |
| Domain | HMG_box | 7.25e-04 | 53 | 62 | 3 | PF00505 | |
| Domain | HMG | 7.66e-04 | 54 | 62 | 3 | SM00398 | |
| Domain | - | 8.08e-04 | 55 | 62 | 3 | 1.10.30.10 | |
| Domain | ELM2 | 8.26e-04 | 13 | 62 | 2 | PF01448 | |
| Domain | ELM2 | 8.26e-04 | 13 | 62 | 2 | PS51156 | |
| Domain | ELM2_dom | 8.26e-04 | 13 | 62 | 2 | IPR000949 | |
| Domain | ELM2 | 8.26e-04 | 13 | 62 | 2 | SM01189 | |
| Domain | SMAD_dom-like | 1.26e-03 | 16 | 62 | 2 | IPR017855 | |
| Domain | - | 1.26e-03 | 16 | 62 | 2 | 2.60.200.10 | |
| Domain | His_PPase_superfam | 1.98e-03 | 20 | 62 | 2 | IPR029033 | |
| Domain | - | 1.98e-03 | 20 | 62 | 2 | 3.40.50.1240 | |
| Domain | Bromodomain_CS | 3.35e-03 | 26 | 62 | 2 | IPR018359 | |
| Domain | SANT_dom | 3.35e-03 | 26 | 62 | 2 | IPR017884 | |
| Domain | SANT | 3.88e-03 | 28 | 62 | 2 | PS51293 | |
| Domain | RRM_1 | 5.04e-03 | 208 | 62 | 4 | PF00076 | |
| Domain | RRM | 5.84e-03 | 217 | 62 | 4 | SM00360 | |
| Domain | Myb_DNA-binding | 6.01e-03 | 35 | 62 | 2 | PF00249 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.79e-05 | 22 | 46 | 3 | MM1370 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 6.27e-05 | 24 | 46 | 3 | M13404 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 7.11e-05 | 25 | 46 | 3 | MM15606 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 7.11e-05 | 25 | 46 | 3 | MM15608 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.44e-04 | 82 | 46 | 4 | MM15922 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.81e-04 | 34 | 46 | 3 | MM15531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 2.16e-04 | 7 | 46 | 2 | M47845 | |
| Pathway | REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 2.16e-04 | 7 | 46 | 2 | M26992 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.34e-04 | 37 | 46 | 3 | M27797 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 2.34e-04 | 37 | 46 | 3 | MM15683 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY | 2.88e-04 | 8 | 46 | 2 | M47847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 3.70e-04 | 9 | 46 | 2 | M47844 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY | 3.70e-04 | 9 | 46 | 2 | M47822 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 4.61e-04 | 10 | 46 | 2 | MM1532 | |
| Pathway | PID_ALK2_PATHWAY | 5.62e-04 | 11 | 46 | 2 | M203 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY | 5.62e-04 | 11 | 46 | 2 | M47848 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 6.73e-04 | 12 | 46 | 2 | M22006 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 6.80e-04 | 53 | 46 | 3 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 7.58e-04 | 55 | 46 | 3 | M39351 | |
| Pathway | WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION | 7.94e-04 | 13 | 46 | 2 | M39378 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 8.85e-04 | 58 | 46 | 3 | MM15149 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 9.25e-04 | 14 | 46 | 2 | M889 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 9.30e-04 | 59 | 46 | 3 | M39886 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.23e-03 | 65 | 46 | 3 | M39682 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.53e-03 | 153 | 46 | 4 | MM15522 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TRERF1 FOXJ2 HOXA5 SOX3 HIVEP3 SOX15 MLXIPL E2F7 SHOX MIDEAS ZNF282 MBNL3 SMAD1 SMAD5 | 7.06e-10 | 908 | 63 | 14 | 19274049 |
| Pubmed | TRERF1 FOXJ2 SOX3 HIVEP3 SOX15 PER3 ATXN1 SMARCE1 BCL3 ARID1A ZNF282 MBNL3 SMAD1 | 1.87e-09 | 808 | 63 | 13 | 20412781 | |
| Pubmed | 2.26e-08 | 4 | 63 | 3 | 36681355 | ||
| Pubmed | 2.26e-08 | 4 | 63 | 3 | 23831410 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 2.26e-08 | 4 | 63 | 3 | 10805751 | |
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 2.26e-08 | 4 | 63 | 3 | 35729324 | |
| Pubmed | A method to identify cDNAs based on localization of green fluorescent protein fusion products. | 2.29e-08 | 17 | 63 | 4 | 10716735 | |
| Pubmed | 3.01e-08 | 268 | 63 | 8 | 33640491 | ||
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 4.58e-08 | 283 | 63 | 8 | 18854154 | |
| Pubmed | 5.65e-08 | 5 | 63 | 3 | 29846695 | ||
| Pubmed | 5.65e-08 | 5 | 63 | 3 | 9128719 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 5.65e-08 | 5 | 63 | 3 | 25809670 | |
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 26048669 | ||
| Pubmed | Selective disruption of genes expressed in totipotent embryonal stem cells. | 1.13e-07 | 6 | 63 | 3 | 1317320 | |
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 15687492 | ||
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 18363099 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.73e-07 | 135 | 63 | 6 | 31077711 | |
| Pubmed | 1.97e-07 | 7 | 63 | 3 | 25846207 | ||
| Pubmed | JCAD WASL MIA2 NF2 DROSHA YLPM1 RNF216 SMARCE1 TAF1 R3HDM1 ARID1A NDUFB7 EP300 | 4.22e-07 | 1285 | 63 | 13 | 35914814 | |
| Pubmed | 4.32e-07 | 83 | 63 | 5 | 28794006 | ||
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 16613856 | ||
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 10452948 | ||
| Pubmed | Interaction between nucleosome assembly protein 1-like family members. | 1.23e-06 | 12 | 63 | 3 | 21333655 | |
| Pubmed | The biogenesis of the coiled body during early mouse development. | 1.23e-06 | 12 | 63 | 3 | 7768196 | |
| Pubmed | 1.83e-06 | 111 | 63 | 5 | 12508121 | ||
| Pubmed | Inhibition of Notch2 by Numb/Numblike controls myocardial compaction in the heart. | 2.03e-06 | 14 | 63 | 3 | 22865640 | |
| Pubmed | 2.10e-06 | 326 | 63 | 7 | 17015433 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | MLXIPL NUMBL DROSHA NAF1 RNF216 SMARCE1 R3HDM1 DENND1A HNRNPC SMAD1 SMAD5 | 2.36e-06 | 1038 | 63 | 11 | 26673895 |
| Pubmed | 2.54e-06 | 15 | 63 | 3 | 18548003 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 18446813 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 21723296 | ||
| Pubmed | Regulation of the levels of Smad1 and Smad5 in MC3T3-E1 cells by Icariine in vitro. | 3.23e-06 | 2 | 63 | 2 | 24297369 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 26711875 | ||
| Pubmed | The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling. | 3.23e-06 | 2 | 63 | 2 | 11451566 | |
| Pubmed | Differing impact of phosphoglycerate mutase 1-deficiency on brown and white adipose tissue. | 3.23e-06 | 2 | 63 | 2 | 35521515 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 22590500 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 25701843 | ||
| Pubmed | Gene network of a phosphoglycerate mutase in muscle wasting in mice. | 3.23e-06 | 2 | 63 | 2 | 25644094 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 30720109 | ||
| Pubmed | BMP-SMAD1/5 Signaling Regulates Retinal Vascular Development. | 3.23e-06 | 2 | 63 | 2 | 32210087 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 30460638 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 17994562 | ||
| Pubmed | T cell-specific deletion of Pgam1 reveals a critical role for glycolysis in T cell responses. | 3.23e-06 | 2 | 63 | 2 | 32709928 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 23387849 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15699051 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 8829551 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 8799132 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.42e-06 | 351 | 63 | 7 | 38297188 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 4.27e-06 | 363 | 63 | 7 | 14691545 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 6.19e-06 | 544 | 63 | 8 | 28473536 | |
| Pubmed | 6.62e-06 | 549 | 63 | 8 | 38280479 | ||
| Pubmed | 7.36e-06 | 21 | 63 | 3 | 21273545 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HNRNPCL1 ANXA11 YLPM1 SMARCE1 ZNF362 TAF1 ARID1A MIDEAS HNRNPC HNRNPCL2 | 7.88e-06 | 954 | 63 | 10 | 36373674 |
| Pubmed | TRERF1 HOXA5 SOX15 ATXN1 YLPM1 SMARCE1 TAF1 R3HDM1 ARID1A MIDEAS EP300 SMAD5 | 8.45e-06 | 1429 | 63 | 12 | 35140242 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 10652350 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 33914812 | ||
| Pubmed | Non-canonical cyclic AMP SMAD1/5/8 signalling in human granulosa cells. | 9.68e-06 | 3 | 63 | 2 | 30953749 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 20851880 | ||
| Pubmed | Regulation of BMP4/Dpp retrotranslocation and signaling by deglycosylation. | 9.68e-06 | 3 | 63 | 2 | 32720893 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 29376829 | ||
| Pubmed | Molecular cloning and nucleotide sequence of murine 2,3-bisphosphoglycerate mutase cDNA. | 9.68e-06 | 3 | 63 | 2 | 2847721 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 21381028 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 20371744 | ||
| Pubmed | Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis. | 9.68e-06 | 3 | 63 | 2 | 32634742 | |
| Pubmed | Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping. | 9.68e-06 | 3 | 63 | 2 | 11250083 | |
| Pubmed | BMP signaling initiates a neural crest differentiation program in embryonic rat CNS stem cells. | 9.68e-06 | 3 | 63 | 2 | 15246821 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 22964636 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 25505291 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 10673036 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 23918166 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 24023003 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 27848974 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 20522807 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 24958256 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 33168191 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 31127639 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 22897816 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 37028703 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 19096363 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 33463047 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 21945631 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 14711801 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 22670624 | ||
| Pubmed | Developmental activation of phosphoglycerate mutase-2 in the testis of the mouse. | 9.68e-06 | 3 | 63 | 2 | 2824255 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 30367512 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 11349124 | ||
| Pubmed | Evidence for an alternative glycolytic pathway in rapidly proliferating cells. | 9.68e-06 | 3 | 63 | 2 | 20847263 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 25165122 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 12649288 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 25880873 | ||
| Pubmed | Two chromatin remodeling activities cooperate during activation of hormone responsive promoters. | 9.68e-06 | 3 | 63 | 2 | 19609353 | |
| Pubmed | Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. | 9.68e-06 | 3 | 63 | 2 | 16247476 | |
| Pubmed | 9.78e-06 | 23 | 63 | 3 | 20875817 | ||
| Pubmed | 9.78e-06 | 23 | 63 | 3 | 28190640 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.28e-05 | 430 | 63 | 7 | 35044719 | |
| Pubmed | 1.43e-05 | 169 | 63 | 5 | 23665500 | ||
| Pubmed | Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. | 1.43e-05 | 26 | 63 | 3 | 15890332 | |
| Pubmed | 1.62e-05 | 446 | 63 | 7 | 24255178 | ||
| Pubmed | Single-cell analysis identifies a key role for Hhip in murine coronal suture development. | 1.80e-05 | 28 | 63 | 3 | 34880220 | |
| Pubmed | Msx1 is essential for proper rostral tip formation of the mouse mandible. | 1.93e-05 | 4 | 63 | 2 | 36566565 | |
| Interaction | SS18L1 interactions | 7.27e-10 | 98 | 63 | 8 | int:SS18L1 | |
| Interaction | PDCD6 interactions | VPS37C MIA2 NF2 ATXN1 DROSHA MAPK1IP1L ANXA11 SMARCE1 ARID1A | 1.38e-08 | 204 | 63 | 9 | int:PDCD6 |
| Interaction | PAX6 interactions | SOX3 ATXN1 SMARCE1 TAF1 PATJ ARID1A MIDEAS HNRNPC EP300 SMAD1 SMAD5 | 1.61e-08 | 366 | 63 | 11 | int:PAX6 |
| Interaction | YAP1 interactions | TRERF1 JCAD WASL HNRNPCL1 NF2 DROSHA YLPM1 SMARCE1 TAF1 PATJ ARID1A MIDEAS PGAM1 HNRNPC EP300 SMAD1 SMAD5 | 2.61e-08 | 1095 | 63 | 17 | int:YAP1 |
| Interaction | DDIT3 interactions | 2.02e-06 | 120 | 63 | 6 | int:DDIT3 | |
| Interaction | TLE3 interactions | 2.42e-06 | 376 | 63 | 9 | int:TLE3 | |
| Interaction | KLF1 interactions | 5.30e-06 | 37 | 63 | 4 | int:KLF1 | |
| Interaction | SMAD1 interactions | 1.06e-05 | 243 | 63 | 7 | int:SMAD1 | |
| Interaction | CRX interactions | 1.41e-05 | 254 | 63 | 7 | int:CRX | |
| Interaction | SOX3 interactions | 2.30e-05 | 18 | 63 | 3 | int:SOX3 | |
| Interaction | ARID1A interactions | 2.41e-05 | 276 | 63 | 7 | int:ARID1A | |
| Interaction | MYOD1 interactions | 3.17e-05 | 194 | 63 | 6 | int:MYOD1 | |
| Interaction | SP7 interactions | 4.45e-05 | 304 | 63 | 7 | int:SP7 | |
| Interaction | HNRNPCL3 interactions | 4.93e-05 | 23 | 63 | 3 | int:HNRNPCL3 | |
| Interaction | PAX9 interactions | 5.38e-05 | 130 | 63 | 5 | int:PAX9 | |
| Interaction | ERG interactions | 6.89e-05 | 223 | 63 | 6 | int:ERG | |
| Interaction | MEN1 interactions | COL8A1 PPP2R5D SETD1B DROSHA YLPM1 SMARCE1 TAF1 ARID1A MIDEAS HNRNPC SMAD1 SMAD5 | 7.03e-05 | 1029 | 63 | 12 | int:MEN1 |
| Interaction | FAM168A interactions | 8.19e-05 | 142 | 63 | 5 | int:FAM168A | |
| Interaction | SOX2 interactions | TRERF1 HOXA5 SOX3 COL8A1 PPP2R5D NF2 ATXN1 YLPM1 SMARCE1 ZNF362 ARID1A MIDEAS HNRNPC EP300 | 1.00e-04 | 1422 | 63 | 14 | int:SOX2 |
| Interaction | EYA4 interactions | 1.11e-04 | 243 | 63 | 6 | int:EYA4 | |
| Interaction | RAMAC interactions | 1.26e-04 | 82 | 63 | 4 | int:RAMAC | |
| Interaction | HOXD13 interactions | 1.26e-04 | 82 | 63 | 4 | int:HOXD13 | |
| Interaction | ARHGEF25 interactions | 1.35e-04 | 32 | 63 | 3 | int:ARHGEF25 | |
| Interaction | TBP interactions | 1.38e-04 | 253 | 63 | 6 | int:TBP | |
| Interaction | HDAC1 interactions | TRERF1 NF2 ATXN1 SMARCE1 TAF1 BCL3 ARID1A MIDEAS HNRNPC EP300 SMAD1 SMAD5 | 1.42e-04 | 1108 | 63 | 12 | int:HDAC1 |
| Interaction | TMC5 interactions | 1.43e-04 | 6 | 63 | 2 | int:TMC5 | |
| Interaction | FSBP interactions | 1.43e-04 | 6 | 63 | 2 | int:FSBP | |
| Interaction | TRERF1 interactions | 1.49e-04 | 33 | 63 | 3 | int:TRERF1 | |
| Interaction | MOV10 interactions | SOX15 HNRNPCL1 NF2 RNF216 SMARCE1 TAF1 R3HDM1 TDP1 ARID1A HNRNPC EP300 MBNL3 HNRNPCL2 | 1.56e-04 | 1297 | 63 | 13 | int:MOV10 |
| Interaction | GSC interactions | 1.59e-04 | 87 | 63 | 4 | int:GSC | |
| Interaction | DROSHA interactions | 1.59e-04 | 87 | 63 | 4 | int:DROSHA | |
| Interaction | HSFY1 interactions | 1.63e-04 | 34 | 63 | 3 | int:HSFY1 | |
| Interaction | KMT2D interactions | 1.85e-04 | 169 | 63 | 5 | int:KMT2D | |
| Interaction | PRMT2 interactions | 1.89e-04 | 91 | 63 | 4 | int:PRMT2 | |
| Interaction | EGR2 interactions | 1.96e-04 | 171 | 63 | 5 | int:EGR2 | |
| Interaction | FOXI1 interactions | 1.97e-04 | 92 | 63 | 4 | int:FOXI1 | |
| Interaction | GDF6 interactions | 2.00e-04 | 7 | 63 | 2 | int:GDF6 | |
| Interaction | SOX17 interactions | 2.23e-04 | 95 | 63 | 4 | int:SOX17 | |
| Interaction | DNTTIP1 interactions | 2.23e-04 | 95 | 63 | 4 | int:DNTTIP1 | |
| Interaction | TEAD1 interactions | 2.24e-04 | 176 | 63 | 5 | int:TEAD1 | |
| Interaction | EMB interactions | 2.27e-04 | 38 | 63 | 3 | int:EMB | |
| Interaction | AR interactions | TRERF1 ATXN1 YLPM1 SMARCE1 ZNF362 TAF1 DCC ARID1A MIDEAS EP300 SMAD1 | 2.28e-04 | 992 | 63 | 11 | int:AR |
| Interaction | WWP2 interactions | VPS37C NF2 DROSHA YLPM1 C3orf70 SMARCE1 PATJ ARID1A MIDEAS HNRNPC | 2.58e-04 | 840 | 63 | 10 | int:WWP2 |
| Interaction | THPO interactions | 2.66e-04 | 8 | 63 | 2 | int:THPO | |
| Interaction | SMARCE1 interactions | 2.72e-04 | 287 | 63 | 6 | int:SMARCE1 | |
| Interaction | LHX3 interactions | 2.82e-04 | 185 | 63 | 5 | int:LHX3 | |
| Interaction | SMAD5 interactions | 2.82e-04 | 101 | 63 | 4 | int:SMAD5 | |
| Interaction | ACTL6A interactions | 2.83e-04 | 289 | 63 | 6 | int:ACTL6A | |
| Interaction | GATA4 interactions | 2.88e-04 | 411 | 63 | 7 | int:GATA4 | |
| Interaction | NFIA interactions | 3.04e-04 | 188 | 63 | 5 | int:NFIA | |
| Interaction | SNIP1 interactions | 3.15e-04 | 417 | 63 | 7 | int:SNIP1 | |
| Interaction | HNF1B interactions | 3.19e-04 | 190 | 63 | 5 | int:HNF1B | |
| Interaction | QKI interactions | 3.19e-04 | 190 | 63 | 5 | int:QKI | |
| Interaction | GLIS2 interactions | 3.39e-04 | 106 | 63 | 4 | int:GLIS2 | |
| Interaction | EN1 interactions | 3.91e-04 | 110 | 63 | 4 | int:EN1 | |
| Interaction | GATA2 interactions | 3.94e-04 | 199 | 63 | 5 | int:GATA2 | |
| Interaction | RARB interactions | 4.02e-04 | 46 | 63 | 3 | int:RARB | |
| Interaction | PAX8 interactions | 4.04e-04 | 111 | 63 | 4 | int:PAX8 | |
| Interaction | FEV interactions | 4.32e-04 | 203 | 63 | 5 | int:FEV | |
| Interaction | TBR1 interactions | 4.33e-04 | 113 | 63 | 4 | int:TBR1 | |
| Interaction | UPF1 interactions | 4.36e-04 | 581 | 63 | 8 | int:UPF1 | |
| Interaction | LDB1 interactions | 4.62e-04 | 115 | 63 | 4 | int:LDB1 | |
| Interaction | PRPF40A interactions | 4.71e-04 | 446 | 63 | 7 | int:PRPF40A | |
| Interaction | TBXT interactions | 4.78e-04 | 116 | 63 | 4 | int:TBXT | |
| Interaction | KRTAP19-7 interactions | 4.94e-04 | 117 | 63 | 4 | int:KRTAP19-7 | |
| Interaction | NFIC interactions | 5.04e-04 | 210 | 63 | 5 | int:NFIC | |
| Interaction | RUNX1 interactions | 5.18e-04 | 324 | 63 | 6 | int:RUNX1 | |
| Interaction | MAGEB18 interactions | 5.19e-04 | 11 | 63 | 2 | int:MAGEB18 | |
| Interaction | CASD1 interactions | 5.19e-04 | 11 | 63 | 2 | int:CASD1 | |
| Interaction | CREBBP interactions | 5.34e-04 | 599 | 63 | 8 | int:CREBBP | |
| Interaction | PAX7 interactions | 6.14e-04 | 124 | 63 | 4 | int:PAX7 | |
| Interaction | CDC40 interactions | 6.14e-04 | 124 | 63 | 4 | int:CDC40 | |
| Interaction | CHD4 interactions | FOXJ2 MLXIPL ATXN1 YLPM1 SMARCE1 ARID1A PGAM1 HNRNPC EP300 HNRNPCL2 | 6.16e-04 | 938 | 63 | 10 | int:CHD4 |
| Interaction | ZNF804A interactions | 6.22e-04 | 12 | 63 | 2 | int:ZNF804A | |
| Interaction | RUNX2 interactions | 6.52e-04 | 126 | 63 | 4 | int:RUNX2 | |
| Interaction | NFIX interactions | 7.17e-04 | 227 | 63 | 5 | int:NFIX | |
| Interaction | KLF3 interactions | 7.31e-04 | 228 | 63 | 5 | int:KLF3 | |
| Interaction | FOXC1 interactions | 7.31e-04 | 228 | 63 | 5 | int:FOXC1 | |
| Interaction | HNRNPC interactions | 7.74e-04 | 634 | 63 | 8 | int:HNRNPC | |
| Interaction | KSR1 interactions | 7.77e-04 | 132 | 63 | 4 | int:KSR1 | |
| Interaction | CTR9 interactions | 8.06e-04 | 233 | 63 | 5 | int:CTR9 | |
| Interaction | SMARCC2 interactions | 8.12e-04 | 353 | 63 | 6 | int:SMARCC2 | |
| Interaction | GAA interactions | 8.45e-04 | 135 | 63 | 4 | int:GAA | |
| GeneFamily | Bisphosphoglycerate phosphatases | 4.13e-05 | 4 | 48 | 2 | 1082 | |
| GeneFamily | SMAD family | 1.91e-04 | 8 | 48 | 2 | 750 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.15e-04 | 17 | 48 | 2 | 486 | |
| GeneFamily | SRY-boxes | 1.15e-03 | 19 | 48 | 2 | 757 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 9.23e-06 | 199 | 64 | 6 | M9180 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-06 | 163 | 64 | 5 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.01e-06 | 192 | 63 | 7 | 6054_DN | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.28e-06 | 199 | 63 | 7 | 6033_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.84e-06 | 171 | 63 | 6 | 6879_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.10e-06 | 172 | 63 | 6 | 5903_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 8.94e-06 | 175 | 63 | 6 | 1014_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.54e-06 | 177 | 63 | 6 | 3227_DN | |
| Drug | Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.75e-05 | 197 | 63 | 6 | 7358_UP | |
| Drug | Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 1.75e-05 | 197 | 63 | 6 | 7350_UP | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.80e-05 | 198 | 63 | 6 | 3540_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.89e-05 | 163 | 63 | 5 | 5594_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.15e-05 | 164 | 63 | 5 | 4388_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.42e-05 | 165 | 63 | 5 | 5625_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.97e-05 | 167 | 63 | 5 | 3979_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.03e-04 | 168 | 63 | 5 | 3868_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.05e-04 | 169 | 63 | 5 | 5231_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.08e-04 | 170 | 63 | 5 | 1050_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.08e-04 | 170 | 63 | 5 | 7043_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.11e-04 | 171 | 63 | 5 | 1000_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.14e-04 | 172 | 63 | 5 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.18e-04 | 173 | 63 | 5 | 4237_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.21e-04 | 174 | 63 | 5 | 6579_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.21e-04 | 174 | 63 | 5 | 5745_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.21e-04 | 174 | 63 | 5 | 3462_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.21e-04 | 174 | 63 | 5 | 1659_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.24e-04 | 175 | 63 | 5 | 5935_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.24e-04 | 175 | 63 | 5 | 1058_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.24e-04 | 175 | 63 | 5 | 6891_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.28e-04 | 176 | 63 | 5 | 6932_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.31e-04 | 177 | 63 | 5 | 873_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.31e-04 | 177 | 63 | 5 | 1645_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.31e-04 | 177 | 63 | 5 | 6434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.31e-04 | 177 | 63 | 5 | 5308_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.31e-04 | 177 | 63 | 5 | 7047_DN | |
| Drug | pararosaniline base; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.31e-04 | 177 | 63 | 5 | 893_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.31e-04 | 177 | 63 | 5 | 7550_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.34e-04 | 178 | 63 | 5 | 4710_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.45e-04 | 181 | 63 | 5 | 6951_DN | |
| Drug | 5-methoxypsoralen | 1.57e-04 | 7 | 63 | 2 | ctd:C022909 | |
| Drug | bp G | 1.72e-04 | 39 | 63 | 3 | CID000448110 | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; MCF7; HG-U133A | 1.74e-04 | 188 | 63 | 5 | 345_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.82e-04 | 190 | 63 | 5 | 6979_UP | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 1.96e-04 | 193 | 63 | 5 | 4125_UP | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A | 1.96e-04 | 193 | 63 | 5 | 4623_DN | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.96e-04 | 193 | 63 | 5 | 4305_DN | |
| Drug | 5248896; Up 200; 11uM; MCF7; HT_HG-U133A_EA | 2.01e-04 | 194 | 63 | 5 | 955_UP | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 2.06e-04 | 195 | 63 | 5 | 7559_UP | |
| Drug | AC1L18R8 | 2.06e-04 | 105 | 63 | 4 | CID000050261 | |
| Drug | LDN 193189 | 2.09e-04 | 8 | 63 | 2 | ctd:C554430 | |
| Drug | Methacholine chloride [62-51-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 6248_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 1511_DN | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 6014_DN | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 3390_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; PC3; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 7123_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 5341_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 2559_DN | |
| Drug | Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 4265_DN | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 5668_DN | |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 5431_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; PC3; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 4568_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 7008_UP | |
| Drug | sulindac; Up 200; 100uM; MCF7; HG-U133A | 2.21e-04 | 198 | 63 | 5 | 168_UP | |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 1679_UP | |
| Drug | Nitrocaramiphen hydrochloride; Down 200; 10.8uM; HL60; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 3125_DN | |
| Drug | Ascorbic acid [50-81-7]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 5407_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.31e-04 | 200 | 63 | 5 | 3477_DN | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.37e-06 | 13 | 61 | 3 | DOID:0050787 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 4.19e-05 | 5 | 61 | 2 | C3281201 | |
| Disease | meningioma (is_implicated_in) | 6.27e-05 | 6 | 61 | 2 | DOID:3565 (is_implicated_in) | |
| Disease | Familial meningioma | 6.27e-05 | 6 | 61 | 2 | C1333989 | |
| Disease | familial meningioma (is_implicated_in) | 6.27e-05 | 6 | 61 | 2 | DOID:4586 (is_implicated_in) | |
| Disease | MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO | 6.27e-05 | 6 | 61 | 2 | 607174 | |
| Disease | Familial meningioma | 6.27e-05 | 6 | 61 | 2 | cv:C3551915 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 1.54e-04 | 50 | 61 | 3 | EFO_0022247 | |
| Disease | Withdrawal Symptoms | 2.39e-04 | 58 | 61 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.39e-04 | 58 | 61 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.39e-04 | 58 | 61 | 3 | C0038587 | |
| Disease | Coffin-Siris syndrome | 3.23e-04 | 13 | 61 | 2 | C0265338 | |
| Disease | T-Cell Lymphoma | 4.95e-04 | 16 | 61 | 2 | C0079772 | |
| Disease | nervousness | 4.95e-04 | 16 | 61 | 2 | NCIT_C74532 | |
| Disease | myeloid white cell count | 6.66e-04 | 937 | 61 | 8 | EFO_0007988 | |
| Disease | Meningioma | 7.03e-04 | 19 | 61 | 2 | C0025286 | |
| Disease | eosinophil percentage of leukocytes | 8.56e-04 | 746 | 61 | 7 | EFO_0007991 | |
| Disease | Adenocarcinoma of large intestine | 1.05e-03 | 96 | 61 | 3 | C1319315 | |
| Disease | Adenoid Cystic Carcinoma | 1.18e-03 | 100 | 61 | 3 | C0010606 | |
| Disease | Kallmann Syndrome | 1.32e-03 | 26 | 61 | 2 | C0162809 | |
| Disease | familial hyperlipidemia | 1.39e-03 | 106 | 61 | 3 | MONDO_0001336 | |
| Disease | Colorectal cancer | 1.43e-03 | 27 | 61 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 1.43e-03 | 27 | 61 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 1.43e-03 | 27 | 61 | 2 | cv:C0009404 | |
| Disease | monocyte count | 1.49e-03 | 1320 | 61 | 9 | EFO_0005091 | |
| Disease | Bilateral Wilms Tumor | 1.65e-03 | 29 | 61 | 2 | C2930471 | |
| Disease | obsolete_red blood cell distribution width | MLXIPL SETD1B SHISA5 MAPK1IP1L YLPM1 R3HDM1 MIDEAS EP300 SMAD1 | 1.71e-03 | 1347 | 61 | 9 | EFO_0005192 |
| Disease | colorectal cancer (is_implicated_in) | 2.04e-03 | 121 | 61 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | neutrophil count | 2.04e-03 | 1382 | 61 | 9 | EFO_0004833 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPTPPNSMPPYLPRT | 1876 | Q09472 | |
| VPQGMALYAPPPPLP | 1256 | Q7Z7A1 | |
| PMVYGPPPPNFSIPF | 1291 | Q7Z7A1 | |
| PPPPNFSIPFIPMGV | 1296 | Q7Z7A1 | |
| AAYPPPPSMPPIGLD | 26 | P50995 | |
| NPQYPMFRAPPPLPP | 516 | Q14738 | |
| ASPAAAPPTLPPYFM | 561 | P54253 | |
| VFQPPLPPDSPRYCM | 111 | A6NLC5 | |
| LVPYVPPPLLPSMFY | 16 | O95424 | |
| MPPALQPFPAPVGPF | 456 | Q9Y6R0 | |
| PYMYPALPPAAPGPL | 191 | A0A3B3IT52 | |
| SGYIMTAAPPPHPPP | 581 | Q15032 | |
| RQPPYGPSAPVPPMT | 1551 | O14497 | |
| PPPMSAIEPKVPYTP | 1351 | P43146 | |
| DGMYSFPARVPPPPP | 121 | O60812 | |
| MYSYPARVPPPPPIA | 136 | P07910 | |
| DGMYSFPARVPPPPP | 121 | B2RXH8 | |
| PKMPPYPPTCAPNLD | 256 | Q9P266 | |
| PPAAMVPSQAPYLVP | 786 | P56645 | |
| SSLPPPMPFPYPLPQ | 316 | Q9H1Q7 | |
| PSPAPPAQPQIYPWM | 166 | P20719 | |
| VPPPPMEPDHPFYSN | 121 | Q8N0Y7 | |
| APHLYPGPSPMYPIP | 521 | Q9P0K8 | |
| AMPSPDVVYGALPPP | 136 | Q02080 | |
| EPDPLQMPTFPPDYG | 16 | P17568 | |
| ATKPTYPPMNPIPAP | 476 | P35240 | |
| PPMVPRQASFFPPPV | 26 | Q7L5N7 | |
| YAVPCPPGHFPPMSP | 511 | O75084 | |
| PPLGPFPVLYSPAMP | 751 | Q96AV8 | |
| NPPPFAPPVMEFPAA | 266 | P17213 | |
| PAVMPPTPPPQGEYL | 571 | P27658 | |
| PSIPANPPMAFNPYI | 121 | Q9NUK0 | |
| MAPYPFPPNPDMNPE | 306 | Q6PJG2 | |
| FPQPPLNPFVPSMPA | 826 | Q8TEH3 | |
| PPGFPMAPPNFFLPS | 411 | P20749 | |
| MAPPNFFLPSPSPPA | 416 | P20749 | |
| VPPPPMEPDHPFYSN | 121 | P18669 | |
| GMPATVYPAPIPPPR | 126 | A1KXE4 | |
| PPPAPFAMRNVYPPR | 1351 | Q96PC5 | |
| YPTPNMPFPELPRPY | 116 | Q8NDC0 | |
| PDFVPFPPPMPPSAQ | 76 | Q9NRR4 | |
| YAQPPSMSSPPPPPA | 281 | P41225 | |
| PMPYPNLAPDVDLTP | 291 | Q12972 | |
| MSKRPSYAPPPTPAP | 1 | Q969G3 | |
| SYAPPPTPAPATQMP | 6 | Q969G3 | |
| PMTPGPYTPQPPDLY | 1636 | P21675 | |
| APYLMFPPPPFGLPI | 236 | O15266 | |
| MPAAPYPMQYPPPYP | 186 | Q8N114 | |
| PLPKFDPSVPPPGYM | 836 | Q9UPS6 | |
| QMPPYAFAHPPFPLP | 796 | Q9NWF9 | |
| LNMGPIPAPYVPPLP | 821 | Q9NWF9 | |
| PPMPSNFPEPPSFSP | 311 | Q9NP71 | |
| QLPADTPPPAYMPPD | 216 | Q99717 | |
| FQMPADTPPPAYLPP | 216 | Q15797 | |
| DTPPPAYLPPEDPMT | 221 | Q15797 | |
| YPTPPPYPFTPFMTV | 176 | Q8IXP5 | |
| PMATFPVPYDLPPEL | 566 | Q9NUW8 | |
| PTPYNPPLAGAPMPL | 216 | O60248 | |
| MAPPAYSLYTPEPPP | 141 | Q8NDY8 | |
| RQGTAPPPMKLPPPY | 1191 | Q8NI35 | |
| YSMPPLPPSLFQAPP | 1176 | Q5T1R4 | |
| PFRQPPSFLPMPYPT | 1216 | Q5T1R4 | |
| YPAQVTAMPPETPLP | 321 | Q9P2J2 | |
| PMPPPPGPALSYQKQ | 106 | P49750 | |
| SYMPPSQSYMPPPQP | 156 | P49750 | |
| PPPPFPNDFFKDMFP | 301 | A1YPR0 | |
| NPYFWPPPPTMPSQL | 21 | Q5T0B9 | |
| SAPMPFPLPVVPDYS | 416 | Q70CQ3 | |
| RMYPPPPPALPSSAP | 341 | O00401 | |
| EEQPQPPLAMPPYPL | 191 | A5D8V6 | |
| PPLAMPPYPLPYSPS | 196 | A5D8V6 | |
| PMPFQFPPFPDRAPV | 66 | Q9UDV7 | |
| LFIPPPPSYNPNPAA | 661 | Q96PN7 | |
| NPIMPQYPFPLPVFD | 416 | Q96HR8 |